Dual role of S100A8 and S100A9 in inflammation-associated cancer

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2009, Pages 329-336

  Németh, Julia ^a   Angel, Peter ^a   Hess, Jochen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

MAPK; NF B; RAGE; ROS; STAT; TLR4

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN A; CALGRANULIN B; CASEIN KINASE II; CCAAT ENHANCER BINDING PROTEIN; GELATINASE A; GELATINASE B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 22; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; STAT PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB;

AUTOIMMUNE DISEASE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; ESOPHAGUS CANCER; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; MALIGNANT TRANSFORMATION; NEOPLASM; NONHUMAN; PAPILLOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 73649112080     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152309789839037     Document Type: Review

References (85)

1. Donato, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol., 2001, 33, 637-668.
2. Heizmann, C.W. The multifunctional S100 protein family. Methods Mol. Biol., 2002, 172, 69-80.
3. Heizmann, C.W.; Fritz, G.; Schafer, B.W. S100 proteins: structure, functions and pathology. Front Biosci., 2002, 7, d1356-1368.
4. Marenholz, I.; Heizmann, C.W.; Fritz, G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun., 2004, 322, 1111-1122.
5. Leukert, N.; Vogl, T.; Strupat, K.; Reichelt, R.; Sorg, C.; Roth, J. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J. Mol. Biol., 2006, 359, 961-972.
6. Bouzidi, F.; Doussiere, J. Binding of arachidonic acid to myeloidrelated proteins (S100A8/A9) enhances phagocytic NADPH oxidase activation. Biochem. Biophys. Res. Commun., 2004, 325, 1060-1065.
7. Kerkhoff, C.; Nacken, W.; Benedyk, M.; Dagher, M.C.; Sopalla, C.; Doussiere, J. The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J., 2005, 19, 467-469.
8. Rammes, A.; Roth, J.; Goebeler, M.; Klempt, M.; Hartmann, M.; Sorg, C. Myeloid-related protein (MRP) 8 and MRP14, calciumbinding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem., 1997, 272, 9496-9502.
9. Vogl, T.; Ludwig, S.; Goebeler, M.; Strey, A.; Thorey, I.S.; Reichelt, R.; Foell, D.; Gerke, V.; Manitz, M.P.; Nacken, W.; Werner, S.; Sorg, C.; Roth, J. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood, 2004, 104, 4260-4268.
10. Ehrchen, J.M.; Sunderkotter, C.; Foell, D.; Vogl, T.; Roth, J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol., 2009.
11. Foell, D.; Wittkowski, H.; Vogl, T.; Roth, J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol., 2007, 81, 28-37.
12. Vogl, T.; Tenbrock, K.; Ludwig, S.; Leukert, N.; Ehrhardt, C.; van Zoelen, M.A.; Nacken, W.; Foell, D.; van der Poll, T.; Sorg, C.; Roth, J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med., 2007, 13, 1042-1049.
13. Srikrishna, G.; Freeze, H.H. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia, 2009, 11, 615-628.
14. Bierhaus, A.; Nawroth, P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia, 2009.
15. Lagasse, E.; Clerc, R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol. Cell Biol., 1988, 8, 2402-2410.
16. Odink, K.; Cerletti, N.; Bruggen, J.; Clerc, R.G.; Tarcsay, L.; Zwadlo, G.; Gerhards, G.; Schlegel, R.; Sorg, C. Two calciumbinding proteins in infiltrate macrophages of rheumatoid arthritis. Nature, 1987, 330, 80-82.
17. Zwadlo, G.; Bruggen, J.; Gerhards, G.; Schlegel, R.; Sorg, C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol., 1988, 72, 510-515.
18. Zenz, R.; Eferl, R.; Kenner, L.; Florin, L.; Hummerich, L.; Mehic, D.; Scheuch, H.; Angel, P.; Tschachler, E.; Wagner, E.F. Psoriasislike skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature, 2005, 437, 369-375.
19. Heizmann, C.W.; Ackermann, G.E.; Galichet, A. Pathologies involving the S100 proteins and RAGE. Subcell Biochem., 2007, 45, 93-138.
20. Nacken, W.; Roth, J.; Sorg, C.; Kerkhoff, C. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc. Res. Tech., 2003, 60, 569-580.
21. Foell, D.; Frosch, M.; Sorg, C.; Roth, J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin. Chim. Acta, 2004, 344, 37-51.
22. Gebhardt, C.; Nemeth, J.; Angel, P.; Hess, J. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol., 2006, 72, 1622-1631.
23. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420, 860-867.
24. de Visser, K.E.; Eichten, A.; Coussens, L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer, 2006, 6, 24-37.
25. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature, 2008, 454, 436-444.
26. Nemeth, J.; Stein, I.; Haag, D.; Riehl, A.; Longerich, T.; Horwitz, E.; Breuhahn, K.; Gebhardt, C.; Schirmacher, P.; Hahn, M.; Ben-Neriah, Y.; Pikarsky, E.; Angel, P.; Hess, J. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology, 2009.
27. Salama, I.; Malone, P.S.; Mihaimeed, F.; Jones, J.L. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol., 2008, 34, 357-364.
28. Cheng, P.; Corzo, C.A.; Luetteke, N.; Yu, B.; Nagaraj, S.; Bui, M.M.; Ortiz, M.; Nacken, W.; Sorg, C.; Vogl, T.; Roth, J.; Gabrilovich, D.I. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med., 2008, 205, 2235-2249.
29. Sinha, P.; Okoro, C.; Foell, D.; Freeze, H.H.; Ostrand-Rosenberg, S.; Srikrishna, G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol., 2008, 181, 4666-4675.
30. Hiratsuka, S.; Watanabe, A.; Aburatani, H.; Maru, Y. Tumourmediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol., 2006, 8, 1369-1375.
31. Hiratsuka, S.; Watanabe, A.; Sakurai, Y.; Akashi-Takamura, S.; Ishibashi, S.; Miyake, K.; Shibuya, M.; Akira, S.; Aburatani, H.; Maru, Y. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol., 2008, 10, 1349-1355.
32. Henke, M.O.; Renner, A.; Rubin, B.K.; Gyves, J.I.; Lorenz, E.; Koo, J.S. Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide. Exp. Lung Res., 2006, 32, 331-347.
33. Benedyk, M.; Sopalla, C.; Nacken, W.; Bode, G.; Melkonyan, H.; Banfi, B.; Kerkhoff, C. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J. Invest. Dermatol., 2007, 127, 2001-2011.
34. Hayashi, N.; Kido, J.; Kido, R.; Wada, C.; Kataoka, M.; Shinohara, Y.; Nagata, T. Regulation of calprotectin expression by interleukin-1alpha and transforming growth factor-beta in human gingival keratinocytes. J. Periodontal Res., 2007, 42, 1-7.
35. Boniface, K.; Bernard, F.X.; Garcia, M.; Gurney, A.L.; Lecron, J.C.; Morel, F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol., 2005, 174, 3695-3702.
36. Liang, S.C.; Tan, X.Y.; Luxenberg, D.P.; Karim, R.; Dunussi-Joannopoulos, K.; Collins, M.; Fouser, L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med., 2006, 203, 2271-2279.
37. Bando, M.; Hiroshima, Y.; Kataoka, M.; Shinohara, Y.; Herzberg, M.C.; Ross, K.F.; Nagata, T.; Kido, J. Interleukin-1alpha regulates antimicrobial peptide expression in human keratinocytes. Immunol. Cell Biol., 2007, 85, 532-537.
38. Fouser, L.A.; Wright, J.F.; Dunussi-Joannopoulos, K.; Collins, M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol. Rev., 2008, 226, 87-102.
39. Xie, M.H.; Aggarwal, S.; Ho, W.H.; Foster, J.; Zhang, Z.; Stinson, J.; Wood, W.I.; Goddard, A.D.; Gurney, A.L. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptorrelated proteins CRF2-4 and IL-22R. J. Biol. Chem., 2000, 275, 31335-31339.
40. Kotenko, S.V.; Izotova, L.S.; Mirochnitchenko, O.V.; Esterova, E.; Dickensheets, H.; Donnelly, R.P.; Pestka, S. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem., 2001, 276, 2725-2732.
41. Kumar, A.; Steinkasserer, A.; Berchtold, S. Interleukin-10 influences the expression of MRP8 and MRP14 in human dendritic cells. Int. Arch. Allergy Immunol., 2003, 132, 40-47.
42. Endoh, Y.; Chung, Y.M.; Clark, I.A.; Geczy, C.L.; Hsu, K. IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA. J. Immunol., 2009, 182, 2258-2268.
43. Lim, S.Y.; Raftery, M.J.; Goyette, J.; Hsu, K.; Geczy, C.L. Oxidative modifications of S100 proteins: functional regulation by redox. J. Leukoc. Biol., 2009.
44. Yen, T.; Harrison, C.A.; Devery, J.M.; Leong, S.; Iismaa, S.E.; Yoshimura, T.; Geczy, C.L. Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli. Blood, 1997, 90, 4812-4821.
45. Gebhardt, C.; Breitenbach, U.; Tuckermann, J.P.; Dittrich, B.T.; Richter, K.H.; Angel, P. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene, 2002, 21, 4266-4276.
46. Schlingemann, J.; Hess, J.; Wrobel, G.; Breitenbach, U.; Gebhardt, C.; Steinlein, P.; Kramer, H.; Furstenberger, G.; Hahn, M.; Angel, P.; Lichter, P. Profile of gene expression induced by the tumour promotor TPA in murine epithelial cells. Int. J. Cancer, 2003, 104, 699-708.
47. Hummerich, L.; Muller, R.; Hess, J.; Kokocinski, F.; Hahn, M.; Furstenberger, G.; Mauch, C.; Lichter, P.; Angel, P. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene, 2006, 25, 111-121.
48. Taccioli, C.; Wan, S.G.; Liu, C.G.; Alder, H.; Volinia, S.; Farber, J.L.; Croce, C.M.; Fong, L.Y. Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology, 2009, 136, 953-966.
49. Henkel, G.W.; McKercher, S.R.; Maki, R.A. Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells. Int. Immunol., 2002, 14, 723-732.
50. Klempt, M.; Melkonyan, H.; Hofmann, H.A.; Eue, I.; Sorg, C. The transcription factors c-myb and C/EBP alpha regulate the monocytic/ myeloic gene MRP14. Immunobiology, 1998, 199, 148-151.
51. Kuruto-Niwa, R.; Nakamura, M.; Takeishi, K.; Nozawa, R. Transcriptional regulation by C/EBP alpha and -beta in the expression of the gene for the MRP14 myeloid calcium binding protein. Cell Struct. Funct., 1998, 23, 109-118.
52. Li, C.; Zhang, F.; Lin, M.; Liu, J. Induction of S100A9 gene expression by cytokine oncostatin M in breast cancer cells through the STAT3 signaling cascade. Breast Cancer Res. Treat., 2004, 87, 123-134.
53. Dechow, T.N.; Pedranzini, L.; Leitch, A.; Leslie, K.; Gerald, W.L.; Linkov, I.; Bromberg, J.F. Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc. Natl. Acad. Sci. USA, 2004, 101, 10602-10607.
54. Banno, T.; Gazel, A.; Blumenberg, M. Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpharegulated genes in epidermal keratinocytes. J. Biol. Chem., 2005, 280, 18973-18980.
55. Schreiber, J.; Jenner, R.G.; Murray, H.L.; Gerber, G.K.; Gifford, D.K.; Young, R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc. Natl. Acad Sci. USA, 2006, 103, 5899-5904.
56. Hess, J.; Angel, P.; Schorpp-Kistner, M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci., 2004, 117, 5965-5973.
57. Gebhardt, C.; Riehl, A.; Durchdewald, M.; Nemeth, J.; Furstenberger, G.; Muller-Decker, K.; Enk, A.; Arnold, B.; Bierhaus, A.; Nawroth, P.P.; Hess, J.; Angel, P. RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med., 2008, 205, 275-285.
58. Turovskaya, O.; Foell, D.; Sinha, P.; Vogl, T.; Newlin, R.; Nayak, J.; Nguyen, M.; Olsson, A.; Nawroth, P.P.; Bierhaus, A.; Varki, N.; Kronenberg, M.; Freeze, H.H.; Srikrishna, G. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis, 2008, 29, 2035-2043.
59. Riehl, A.; Nemeth, J.; Angel, P.; Hess, J. The receptor RAGE: Bridging inflammation and cancer. Cell Commun. Signal, 2009, 7, 12.
60. Nukui, T.; Ehama, R.; Sakaguchi, M.; Sonegawa, H.; Katagiri, C.; Hibino, T.; Huh, N.H. S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J. Cell Biochem., 2008, 104, 453-464.
61. Ghavami, S.; Rashedi, I.; Dattilo, B.M.; Eshraghi, M.; Chazin, W.J.; Hashemi, M.; Wesselborg, S.; Kerkhoff, C.; Los, M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol., 2008, 83, 1484-1492.
62. Yui, S.; Nakatani, Y.; Mikami, M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull., 2003, 26, 753-760.
63. Tugizov, S.; Berline, J.; Herrera, R.; Penaranda, M.E.; Nakagawa, M.; Palefsky, J. Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex. J. Virol., 2005, 79, 1099-1112.
64. Murao, S.; Collart, F.R.; Huberman, E. A protein containing the cystic fibrosis antigen is an inhibitor of protein kinases. J. Biol. Chem., 1989, 264, 8356-8360.
65. Dell'oste, V.; Azzimonti, B.; Mondini, M.; De Andrea, M.; Borgogna, C.; Mesturini, R.; Accardi, R.; Tommasino, M.; Landolfo, S.; Dianzani, U.; Gariglio, M. Altered expression of UVB-induced cytokines in human papillomavirus- immortalized epithelial cells. J. Gen. Virol., 2008, 89, 2461-2466.
66. Lo, W.Y.; Lai, C.C.; Hua, C.H.; Tsai, M.H.; Huang, S.Y.; Tsai, C.H.; Tsai, F.J. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J. Proteome Res., 2007, 6, 2143-2151.
67. Yui, S.; Mikami, M.; Yamazaki, M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J. Leukoc. Biol., 1995, 58, 650-658.
68. Yui, S.; Mikami, M.; Tsurumaki, K.; Yamazaki, M. Growthinhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol., 1997, 61, 50-57.
69. Ghavami, S.; Kerkhoff, C.; Los, M.; Hashemi, M.; Sorg, C.; Karami-Tehrani, F. Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol., 2004, 76, 169-175.
70. Ghavami, S.; Kerkhoff, C.; Chazin, W.J.; Kadkhoda, K.; Xiao, W.; Zuse, A.; Hashemi, M.; Eshraghi, M.; Schulze-Osthoff, K.; Klonisch, T.; Los, M. S100A8/9 induces cell death via a novel, RAGEindependent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta, 2008, 1783, 297-311.
71. Chan, E.C.; Jiang, F.; Peshavariya, H.M.; Dusting, G.J. Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol. Ther., 2009, 122, 97-108.
72. Wu, W.S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev., 2006, 25, 695-705.
73. Benhar, M.; Engelberg, D.; Levitzki, A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep., 2002, 3, 420-425.
74. Mendelson, K.G.; Contois, L.R.; Tevosian, S.G.; Davis, R.J.; Paulson, K.E. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl .Acad. Sci. USA, 1996, 93, 12908-12913.
75. Sakurai, T.; He, G.; Matsuzawa, A.; Yu, G.Y.; Maeda, S.; Hardiman, G.; Karin, M. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell, 2008, 14, 156-165.
76. Moon, A.; Yong, H.Y.; Song, J.I.; Cukovic, D.; Salagrama, S.; Kaplan, D.; Putt, D.; Kim, H.; Dombkowski, A.; Kim, H.R. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res., 2008, 6, 1544-1553.
77. Yong, H.Y.; Moon, A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm. Res., 2007, 30, 75-81.
78. Arai, K.; Takano, S.; Teratani, T.; Ito, Y.; Yamada, T.; Nozawa, R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr. Cancer Drug Targets, 2008, 8, 243-252.
79. El-Rifai, W.; Moskaluk, C.A.; Abdrabbo, M.K.; Harper, J.; Yoshida, C.; Riggins, G.J.; Frierson, H.F. Jr.; Powell, S.M. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res., 2002, 62, 6823-6826.
80. Wagner, E.F.; Nebreda, A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer, 2009, 9, 537-549.
81. Andrassy, M.; Igwe, J.; Autschbach, F.; Volz, C.; Remppis, A.; Neurath, M.; Schleicher, E.; Humpert, P.; Wendt, T.; Liliensiek, B.; Morcos, M.; Schiekofer, S.; Thiele, K.; Chen, J.; Kientsch-Engel, R.; Schmidt, A.; Stremmel, W.; Stern, D.; Katus, H.; Nawroth, P.; Bierhaus, A. Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation. Am. J. Pathol., 2006, 169, 1223-1237.
82. Sunahori, K.; Yamamura, M.; Yamana, J.; Takasugi, K.; Kawashima, M.; Yamamoto, H.; Chazin, W.J.; Nakatani, Y.; Yui, S.; Makino, H. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res. Ther., 2006, 8, R69.
83. Hermani, A.; De Servi, B.; Medunjanin, S.; Tessier, P.A.; Mayer, D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res., 2006, 312, 184-197.
84. Roesch Ely, M.; Nees, M.; Karsai, S.; Magele, I.; Bogumil, R.; Vorderwulbecke, S.; Ruess, A.; Dietz, A.; Schnolzer, M.; Bosch, F.X. Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur. J. Cell Biol., 2005, 84, 431-444.
85. 2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene, 2004, 23, 1291-1299.